Yesterday, Aug. 2, 2016, 97 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $43.70 to $50,903,280.00.

Highlighted Stocks Traded by Insiders:

SunCoke Energy (SXC) - FREE Research Report

Mangrove Partners Master Fund, Ltd., who is 10% Owner at SunCoke Energy, bought 215,517 shares at $7.20 on Aug. 2, 2016. Following this transaction, the 10% Owner owned 8.1 million shares meaning that the stake was boosted by 2.72% with the 215,517-share transaction.

The shares most recently traded at $7.25, up $0.05, or 0.71% since the insider transaction. Historical insider transactions for SunCoke Energy go as follows:

  • 4-Week # shares bought: 291,478
  • 12-Week # shares bought: 291,478
  • 24-Week # shares bought: 291,478

The average volume for SunCoke Energy has been 562,200 shares per day over the past 30 days. SunCoke Energy has a market cap of $453.0 million and is part of the basic materials sector and metals & mining industry. Shares are up 119.88% year-to-date as of the close of trading on Friday.

SunCoke Energy, Inc. operates as an independent producer of coke in the Americas. The company operates through four segments: Domestic Coke, Brazil Coke, India Coke, and Coal Logistics. The stock currently has a dividend yield of 14.42%. Currently, there are 2 analysts who rate SunCoke Energy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SXC - FREE

TheStreet Quant Ratings rates SunCoke Energy as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins and generally disappointing historical performance in the stock itself. Get the full SunCoke Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Boston Scientific (BSX) - FREE Research Report

Mahoney Michael F, who is President & CEO at Boston Scientific, sold 44,400 shares at $24.44 on Aug. 2, 2016. Following this transaction, the President & CEO owned 1.4 million shares meaning that the stake was reduced by 3.1% with the 44,400-share transaction.

The shares most recently traded at $24.43, down $0.01, or 0.03% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 107,000
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 217,029
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 947,826

The average volume for Boston Scientific has been 10.9 million shares per day over the past 30 days. Boston Scientific has a market cap of $33.0 billion and is part of the health care sector and health services industry. Shares are up 31.67% year-to-date as of the close of trading on Friday.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. Currently, there are 15 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Kingsway Financial Services (KFS) - FREE Research Report

Swets Larry G Jr, who is CEO and President at Kingsway Financial Services, bought 377 shares at $5.52 on Aug. 2, 2016. Following this transaction, the CEO and President owned 2.1 million shares meaning that the stake was boosted by 0.02% with the 377-share transaction.

Baqar Hassan, who is Vice President at Kingsway Financial Services, bought 128 shares at $5.52 on Aug. 2, 2016. Following this transaction, the Vice President owned 148,336 shares meaning that the stake was boosted by 0.09% with the 128-share transaction.

Hickey William August Jr, who is COO, CFO and EVP at Kingsway Financial Services, bought 272 shares at $5.52 on Aug. 2, 2016. Following this transaction, the COO, CFO and EVP owned 294,978 shares meaning that the stake was boosted by 0.09% with the 272-share transaction.

Fitzgerald John Taylor Maloney, who is Executive Vice President at Kingsway Financial Services, bought 183 shares at $5.49 on Aug. 2, 2016. Following this transaction, the Executive Vice President owned 351,756 shares meaning that the stake was boosted by 0.05% with the 183-share transaction.

The shares most recently traded at $5.43, down $0.06, or 1.11% since the insider transaction. Historical insider transactions for Kingsway Financial Services go as follows:

  • 4-Week # shares bought: 67,300
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 189,875
  • 12-Week # shares sold: 25,000
  • 24-Week # shares bought: 209,269
  • 24-Week # shares sold: 25,000

The average volume for Kingsway Financial Services has been 16,800 shares per day over the past 30 days. Kingsway Financial Services has a market cap of $108.8 million and is part of the financial sector and insurance industry. Shares are up 20.35% year-to-date as of the close of trading on Friday.

Kingsway Financial Services Inc., through its subsidiaries, provides property and casualty insurance products in the United States. The company operates in two segments, Insurance Underwriting and Insurance Services. Currently, there are no analysts who rate Kingsway Financial Services a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KFS - FREE

TheStreet Quant Ratings rates Kingsway Financial Services as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and poor profit margins. Get the full Kingsway Financial Services Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.